Articles

Parkinson’s disease: animal models and dopaminergic cell vulnerability

• Javier Blesa
• Serge Przedborski

Brain renin-angiotensin system and dopaminergic cell vulnerability

• Jose L. Labandeira-García
• Pablo Garrido-Gil
• Jannette Rodriguez-Pallares
• Rita Valenzuela
• Ana Borrajo
• Ana I. Rodríguez-Perez

Editorial: Factors contributing to dopaminergic cell death

in Molecular Signalling and Pathways

• Sandra Blaess
• Antonio J. Herrera

HMGB1 Mediates Autophagy Dysfunction via Perturbing Beclin1-Vps34 Complex in Dopaminergic Cell Model

in Molecular Signalling and Pathways

• Jinsha Huang
• Jiaolong Yang
• Yan Shen
• Haiyang Jiang
• Chao Han
• Guoxin Zhang
• Ling Liu
• Xiaoyun Xu
• Jie Li
• Zhicheng Lin

Olfactory Sensory Activity Modulates Microglial-Neuronal Interactions during Dopaminergic Cell Loss in the Olfactory Bulb

in Non-Neuronal Cells

• Bryce D. Grier
• Leonardo Belluscio
• Claire E. J. Cheetham

Peripheral Inflammation Enhances Microglia Response and Nigral Dopaminergic Cell Death in an in vivo MPTP Model of Parkinson’s Disease

in Non-Neuronal Cells

• Irene García-Domínguez
• Karolina Veselá
• Juan García-Revilla
• Alejandro Carrillo-Jiménez
• María Angustias Roca-Ceballos
• Marti Santiago
• Rocío M. de Pablos
• José L. Venero

Cerebroventricular Microinjections of MPTP on Adult Zebrafish Induces Dopaminergic Neuronal Death, Mitochondrial Fragmentation, and Sensorimotor Impairments

in Neurodegeneration

• Michael Kalyn
• Marc Ekker

Mitochondrial ferritin in the regulation of brain iron homeostasis and neurodegenerative diseases

in Drug Metabolism and Transport

• Guofen Gao
• Yan-Zhong Chang

A computational model of basal ganglia and its role in memory retrieval in rewarded visual memory tasks

• Julien Vitay
• Fred H Hamker

Pentazocine Protects SN4741 Cells Against MPP+-Induced Cell Damage via Up-Regulation of the Canonical Wnt/β-Catenin Signaling Pathway

in Parkinson’s Disease and Aging-related Movement Disorders

• Jiancai Wang
• Jintao Gu
• Hao Wu
• Gang Zhu
• Dayun Feng
• Yuqian Li
• Wei Guo
• Keyong Tian
• Guodong Gao
• Li Gao

Elevated Hapln2 Expression Contributes to Protein Aggregation and Neurodegeneration in an Animal Model of Parkinson's Disease

in Parkinson’s Disease and Aging-related Movement Disorders

• Qinqin Wang
• Qinbo Zhou
• Shuzhen Zhang
• Wei Shao
• Yanqing Yin
• Yandong Li
• Jincan Hou
• Xinhua Zhang
• Yongshun Guo
• Xiaomin Wang

Combined α2- and D2-receptor blockade activates noradrenergic and dopaminergic neurons, but extracellular dopamine in the prefrontal cortex is determined by uptake and release from noradrenergic terminals

in Neuropharmacology

• Claudia Sagheddu
• Paola Devoto
• Sonia Aroni
• Pierluigi Saba
• Marco Pistis
• Gian Luigi Gessa

AMBRA1-Mediated Mitophagy Counteracts Oxidative Stress and Apoptosis Induced by Neurotoxicity in Human Neuroblastoma SH-SY5Y Cells

in Cellular Neuropathology

• Anthea Di Rita
• Pasquale D’Acunzo
• Luca Simula
• Silvia Campello
• Flavie Strappazzon
• Francesco Cecconi

Lack of Parkinsonian Pathology and Neurodegeneration in Mice After Long-Term Injections of a Proteasome Inhibitor in Olfactory Bulb and Amygdala

in Parkinson’s Disease and Aging-related Movement Disorders

• Natalia Lopez-Gonzalez del Rey
• Tiziano Balzano
• Lucia Martin-Rodriguez
• Constanza Salinas-Rebolledo
• Ines Trigo-Damas
• Alejandro Rojas-Fernandez
• Lydia Alvarez-Erviti
• Javier Blesa

From the Gut to the Brain and Back: Therapeutic Approaches for the Treatment of Network Dysfunction in Parkinson's Disease

in Movement Disorders

• Giovanna Paolone

Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson’s Disease

in Neurodegeneration

• Paula A. Q. Videira
• Margarida Castro-Caldas